106 related articles for article (PubMed ID: 12200876)
1. [White-coat hypertension and risk factors in recently diagnosed hypertensive patients].
Aguirre-Ramos R; Trujillo-Hernández B; Huerta M; Trujillo X; Vásquez C; Millán-Guerrero RO
Gac Med Mex; 2002; 138(4):319-24. PubMed ID: 12200876
[TBL] [Abstract][Full Text] [Related]
2. [Frequency of white coat arterial hypertension in mild hypertension. Profile of cardiovascular risk and early organic involvement].
Hernández del Rey R; Armario P; Sánchez P; Castellsague J; Pont F; Cárdenas G; Pardell H
Med Clin (Barc); 1996 May; 106(18):690-4. PubMed ID: 8801371
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular and renal events in uncomplicated mild hypertensive patients with sustained and white coat hypertension.
Pierdomenico SD; Lapenna D; Bucci A; Di Iorio A; Neri M; Cuccurullo F; Mezzetti A
Am J Hypertens; 2004 Oct; 17(10):876-81. PubMed ID: 15485748
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and clinical correlates of white coat hypertension in chronic kidney disease.
Minutolo R; Borrelli S; Scigliano R; Bellizzi V; Chiodini P; Cianciaruso B; Nappi F; Zamboli P; Conte G; De Nicola L
Nephrol Dial Transplant; 2007 Aug; 22(8):2217-23. PubMed ID: 17420167
[TBL] [Abstract][Full Text] [Related]
5. Relationship between insulin resistance and end-organ damage in white coat hypertension.
Tunçkale A; Aran SN; Karpuz H; Dirican A
Am J Hypertens; 2004 Nov; 17(11 Pt 1):1011-6. PubMed ID: 15533726
[TBL] [Abstract][Full Text] [Related]
6. Nocturnal blood pressure fall and metabolic syndrome score in patients with white coat hypertension.
Vyssoulis G; Karpanou E; Adamopoulos D; Kyvelou SM; Gymnopoulou E; Cokkinos D; Stefanadis C
Blood Press Monit; 2008 Oct; 13(5):251-6. PubMed ID: 18799949
[TBL] [Abstract][Full Text] [Related]
7. [Clinical characteristics of the white coat hypertension].
Vinyoles E; de la Figuera M
Med Clin (Barc); 1995 Sep; 105(8):287-91. PubMed ID: 7475478
[TBL] [Abstract][Full Text] [Related]
8. Are metabolic risk factors and target organ damage more frequent in masked hypertension than in white coat hypertension?
Yoon HJ; Ahn Y; Park JB; Park CG; Youn HJ; Choi DJ; Shin JH; Kim DW; Rim SJ; Bae JH;
Clin Exp Hypertens; 2010; 32(7):480-5. PubMed ID: 21029014
[TBL] [Abstract][Full Text] [Related]
9. Endothelium and angiogenesis in white coat hypertension.
Karter Y; Aydin S; Curgunlu A; Uzun H; Ertürk N; Vehid S; Kutlu A; Simsek G; Yücel R; Arat A; Ozturk E; Erdine S
J Hum Hypertens; 2004 Nov; 18(11):809-14. PubMed ID: 15215878
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte DNA damage and total antioxidant status in patients with white-coat hypertension and sustained hypertension.
Yildiz A; Gür M; Yilmaz R; Demirbağ R; Celik H; Aslan M; Koçyiğit A
Turk Kardiyol Dern Ars; 2008 Jun; 36(4):231-8. PubMed ID: 18765966
[TBL] [Abstract][Full Text] [Related]
11. White coat hypertension is a cardiovascular risk factor: a 10-year follow-up study.
Gustavsen PH; Høegholm A; Bang LE; Kristensen KS
J Hum Hypertens; 2003 Dec; 17(12):811-7. PubMed ID: 14704724
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and predictors of white-coat hypertension in a large database of ambulatory blood pressure monitoring.
Abir-Khalil S; Zaîmi S; Tazi MA; Bendahmane S; Bensaoud O; Benomar M
East Mediterr Health J; 2009; 15(2):400-7. PubMed ID: 19554987
[TBL] [Abstract][Full Text] [Related]
13. Relationship between aortic stiffness and cardiovascular risk factors in a population of normotensives, white-coat normotensives, white-coat hypertensives, sustained hypertensives and diabetic patients.
Silva JA; Barbosa L; Bertoquini S; Maldonado J; Polónia J
Rev Port Cardiol; 2004 Dec; 23(12):1533-47. PubMed ID: 15732656
[TBL] [Abstract][Full Text] [Related]
14. Impaired arterial elasticity in young patients with white-coat hypertension.
Longo D; Zaetta V; Perkovic D; Frezza P; Ragazzo F; Mos L; Santonastaso M; Garbelotto R; Benetos A; Palatini P
Blood Press Monit; 2006 Oct; 11(5):243-9. PubMed ID: 16932033
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress in white coat hypertension; role of paraoxonase.
Uzun H; Karter Y; Aydin S; Curgunlu A; Simşek G; Yücel R; Vehiyd S; Ertürk N; Kutlu A; Benian A; Yaldiran A; Oztürk E; Erdine S
J Hum Hypertens; 2004 Jul; 18(7):523-8. PubMed ID: 14985779
[TBL] [Abstract][Full Text] [Related]
16. Comparison between continuous ambulatory arterial blood pressure monitoring and standard blood pressure measurements among patients of younger and older age group.
Babić BK; Bagatin J; Kokić S; Ostojić SB; Carević V; Berović N
Coll Antropol; 2009 Mar; 33(1):65-70. PubMed ID: 19408605
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of the white-coat effect at multiple visits before and during treatment.
Verberk WJ; Kroon AA; Thien T; Lenders JW; van Montfrans GA; Smit AJ; de Leeuw PW
J Hypertens; 2006 Dec; 24(12):2357-63. PubMed ID: 17082716
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic importance of white coat and masked hypertension].
Gustavsen P; Hansen TW
Ugeskr Laeger; 2009 Jun; 171(24):2019-22. PubMed ID: 19523366
[TBL] [Abstract][Full Text] [Related]
19. White coat effect and white coat hypertension in pediatric patients.
Matsuoka S; Kawamura K; Honda M; Awazu M
Pediatr Nephrol; 2002 Nov; 17(11):950-3. PubMed ID: 12432440
[TBL] [Abstract][Full Text] [Related]
20. Circulating homocysteine levels in sustained and white coat hypertension.
Pierdomenico SD; Bucci A; Lapenna D; Lattanzio FM; Talone L; Cuccurullo F; Mezzetti A
J Hum Hypertens; 2003 Mar; 17(3):165-70. PubMed ID: 12624606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
